April 01, 2025

Choice™ 2 Veneer Cement

Learn how BISCO's CHOICE 2 Veneer Cement provides color stability, a wide range of shades, and excellent esthetics for restorations. Recommended by Dr. Luis Abrahante from Mountain Brook, Alabama. Find out more at bisco.com!

Inside Dentistry

April 01, 2025

Evaluating Sentinel Node Positivity in Melanoma

A systematic review and meta-analysis identified 21 risk prediction models for sentinel lymph node biopsy positivity in melanoma, revealing a pooled C statistic of 0.78 and highlighting the need for further research to optimize their clinical implementation.

Conexiant

April 01, 2025

Opening Lines: The Latest News in Ophthalmology

The latest news in ophthalmology. Plus, introducing our new wellness series

Ophthalmic Professional

April 01, 2025

Cemiplimab Effective for Advanced cSCC

Meta-analysis of 19 studies reveals promising 54.5% objective response rate and manageable safety profile for PD-1 inhibitor in treating advanced cutaneous squamous cell carcinoma.

Conexiant

April 01, 2025

Quick Hits

The latest news in ophthalmology

Ophthalmology Management

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 28, 2025

Novel Limonene-Lipid Formulation May Help Alleviate Xerostomia in Patients With Cancer

Researchers examined the combination of a novel lipid formulation and a natural citrus essential oil to determine whether it may relieve xerostomia among patients with cancer.

The ASCO Post

March 27, 2025

Trends in Spironolactone Prescribing Among Young Women

A cohort study of 38 million insured females aged 12 to 40 years found a marked increase in spironolactone prescriptions, most commonly for acne and other androgen-related conditions.

Conexiant

March 25, 2025

Does Bicalutamide Help Hair Loss?

A new randomized clinical trial found no added benefit from combining bicalutamide with minoxidil in the treatment of female pattern hair loss, contrasting with findings from previous retrospective studies and noting that further research on antiandrogen therapy is needed.

Conexiant